FDA Approves New Ovarian Cancer Maintenance Treatment: PARP Inhibitor Combination Drug Approval

FDA Approves New Ovarian Cancer Maintenance Treatment: PARP Inhibitor Combination Drug Approval

×

SN Local - Explore Ovarian Cancer expertise and community near you:

NOW
PLAYING
PARP Inhibitor Side Effects
NOW
PLAYING
Deciding on PARP Inhibitors for Ovarian Cancer
NOW
PLAYING
PARP Inhibitors for Ovarian Cancer Treatment: Weighing Risks and Benefits
NOW
PLAYING
Who Should Be Taking PARP Inhibitors for Ovarian Cancer?
NOW
PLAYING
How Does Bevacizumab (Avastin) Work As Part of Ovarian Cancer Treatment?
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.